BTK inhibitor 17

CAS: 1858206-76-4 货号: B647555 分子式: C25H24N6O3 分子量: 456.50
有货
级别和纯度: ≥98%
别名
BTK抑制剂17
储存条件
-20°C储存
运输条件
超低温运输
★
规格
库存
价格
数量
1mg
B647555-1mg
期货 Stock Image
¥1,714.90
5mg
B647555-5mg
期货 Stock Image
¥4,500.90
10mg
B647555-10mg
期货 Stock Image
¥8,000.90
25mg
B647555-25mg
期货 Stock Image
¥16,500.90
50mg
B647555-50mg
期货 Stock Image
¥25,500.90
100mg
B647555-100mg
期货 Stock Image
¥38,000.90
请输入您要添加的产品数量
🧪
为什么选择此级别

提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述


BTK inhibitor 17 is a potent and orally active irreversible BTK inhibitor with an IC 50 of 2.1 nM. BTK inhibitor 17 can be used for rheumatoid arthritis research

In Vitro

BTK inhibitor 17 (compound 8) could covalently bind to Cys481 and formed an HB network with hinge key residues Met477, Glu475, and gatekeeper Thr474. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

BTK inhibitor 17 (compound 8; 3-10 mg/kg; oral gavage; daily; for 28 days) treatment inhibits the significant progression of the disease and exhibits a clear dose-dependent reduction per paw clinical scores, and no significant body weight loss is observed for all different dosages . BTK inhibitor 17 (compound 8) shows >95% plasma protein binding across three species of human, rat, and mouse. After an intravenous injection, the half-life (rat, 0.32 h; mice, 0.42 h), clearance (rat, 54.6 mL/min/kg; mice, 31.3 mL/min/kg), volume of distribution (rat, 1.55 L/kg; mice, 0.82 L/kg), and AUC exposure (rat, 604 ng.h/mL; mice, 576 ng.h/mL) are observed in two species. After oral administration, BTK inhibitor 17 exhibits higher C max (rat, 466 ng/mL; mice, 252 ng/mL) and plasma exposure (rat, 642 ng.h/mL; mice, 128 ng.h/mL) with a favorable oral bioavailability (rat, 23.7%; mice, 11.2%) . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Balb/C mice injected with collagen Dosage: 3 mg/kg or 10 mg/kg Administration: Oral gavage; daily; for 28 days Result: Inhibited the significant progression of the disease and exhibited a clear dose-dependent reduction per paw clinical scores.

Form:Solid

IC50& Target:IC50: 2.1 nM (BTK)

规格

别名
BTK抑制剂17
规格或纯度
≥98%
英文名称
BTK inhibitor 17
生化机理
BTK 抑制剂 17 是一种强效的口服活性不可逆 BTK 抑制剂,其 IC 50 为 2.1 nM。BTK 抑制剂 17 可用于类风湿性关节炎的研究。
储存条件
-20°C储存
运输条件
超低温运输
作用类型
抑制剂
纯度
≥98%
名称和识别符
分子类型
小分子
分子量
456.50

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

化学和物理性质
溶解性
DMSO : 100 mg/mL (219.06 mM; Need ultrasonic)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器